首页> 外文会议>International Conference on Logistics Operations Management >Determining a new multi-level criteria evaluation strategy for medicines suppliers
【24h】

Determining a new multi-level criteria evaluation strategy for medicines suppliers

机译:确定药品供应商新的多级标准评估策略

获取原文

摘要

Today, in the biomedical services in hospitals, all types of medication errors including missed dose, wrong dosage forms, wrong packaging, wrong route, etc., are a big deal for better patient care. All these errors are principally related to supplier's poor services; therefore medication errors can be reduced significantly by improving suppliers' performances. To monitor these performances, an effective evaluation method is essential, and the choice of the appropriate criteria to be based in is paramount; although, when our decision problem considers several levels of criteria, the alternatives performance becomes difficult o evaluate. In this paper, we shed light on two principle points; the first one proposes a multi-level criteria strategy to evaluate suppliers based on Topsis method, while determining attributes weights by entropy approach. And the second one determines three levels of critical criteria to be based in, in the proposed evaluation process. The proposed strategy is validated through a comparison study, whose results analysis has shown the ineffectiveness of the single level criteria in the evaluation system.
机译:如今,在医院的生物医学服务中,所有类型的药物误差包括错过剂量,错误的剂型,错误的包装,错误的路线等,是更好的患者护理的重要交易。所有这些错误都主要与供应商的差的服务有关;因此,通过改善供应商的性能,可以显着减少药物误差。为了监控这些性能,有效的评估方法至关重要,并且选择适当的标准是至关重要的;虽然,当我们的决策问题考虑了几个级别的标准时,替代性能变得难以评估。在本文中,我们阐明了两个原理点;第一个提出了一种基于TOPSIS方法来评估供应商的多级标准策略,同时通过熵方法确定属性权重。第二个,在拟议的评估过程中,确定了三个级别的关键标准。通过比较研究验证了拟议的策略,其结果分析表明了评估系统中单级标准的无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号